If I’d invested £1,000 in AstraZeneca shares five years ago, here’s what I’d have now

AstraZeneca shares have been the FTSE 100’s standout star over the past five years. But how much would I have made buying this stock five years ago?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Engineer Project Manager Talks With Scientist working on Computer

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At present, the total value of the UK’s FTSE 100 index is almost £2.03trn. Yet just 10 mega-cap firms account for £1trn (49.1%) of this total. The biggest Footsie company today is pharmaceutical giant AstraZeneca (LSE: AZN), whose shares have soared in recent years.

The rise and rise of AstraZeneca shares

On Friday, the AstraZeneca share price closed at 11,746p, down 50p. This values the UK’s biggest healthcare company at £180.8bn. Therefore, this business alone accounts for 8.9% of the entire FTSE 100.

Why is AstraZeneca worth so much? Because its shares have been surging for years. Here’s how the share price has performed over eight periods:

One week-2.2%
One month+5.2%
Three months+10.4%
Six months+16.0%
One year+11.2%
Two years+56.5%
Three years+43.5%
Five years+135.3%

Remarkably, the stock has produced positive returns over all periods ranging from one month to five years. The only fall was a modest decline last week.

Thanks to this outstanding performance, the shares have thrashed the FTSE 100 (+4%) over the past half-decade. In fact, this stock is the Footsie’s #1 performer over the last five years.

However, the above returns exclude cash dividends, which would add a few percentage points a year to these figures.

Investing £1,000 five years ago

To answer the question in my title: how much would I have today had I bought £1,000 of AstraZeneca stock exactly five years ago?

The shares’ 135.3% capital gain over 60 months would have turned my original £1,000 into £2,353 today. That works out at a compound annual growth rate of 18.7% a year. Nice.

However, AstraZeneca shares pay out regular dividends in US dollars. Here are the last five years’ payouts:

Financial year-endTotal dividendsIn £s today
31/12/2022$2.90£2.31
31/12/2021$2.87£2.29
31/12/2020$2.80£2.23
31/12/2019$2.80£2.23
31/12/2018$2.80£2.23
Total$14.17£11.30

My table shows total dividends per share paid out over the past five years add up to £11.30.

The original £1,000 investment would have bought 20 AstraZeneca shares at just under £50 each in 2018. Thus, my total dividends would come to £11.30 times 20, which is £225.90.

Hence, my total return (capital gain plus cash dividends) from AstraZeneca stock over five years would be £2,353 plus £225.90, which equals £2,578.90.

That’s a total return of 157.9%, which works out at a compound annual growth rate of almost 20.9% a year. How I’d love to have earned similar returns from every stock in my portfolio.

What about the future?

Investors who jumped aboard the AstraZeneca bandwagon have seen the company’s revenues more than double over the past five years, leaping from $22.1bn in 2018 to $44.4bn in 2022.

Of course, there’s no guarantee that the rapid growth in both revenues and the share price will continue for another five years. But analysts highly rate CEO Pascal Soriot (appointed back in October 2012) and his leadership team.

That said, I wouldn’t buy the stock today. This is only because my wife and I already have large sums invested in FTSE 100 index trackers. And remember that AstraZeneca accounts for almost 9% of the entire Footsie. Hence, my family already has a decent stake in this great British business!

Cliff D'Arcy has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services, such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool, we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Seeking New Year bargains? FTSE 100 index shares remain on sale!

These FTSE 100 index stocks have surged in value in 2026. But they still offer plenty for value investors to…

Read more »

Landlady greets regular at real ale pub
Investing Articles

Will the crashed Diageo share price rebound 63% in 2026?

Diageo's share price has collapsed by more than a third since 1 January. But these brokers expect the FTSE 100…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

1 top investment trust to consider from the FTSE 250 

This niche FTSE 250 investment trust offers exposure to one of Asia's fastest growing economies, potentially setting it up for…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

2 high risk/high reward stock market picks to consider in 2026

The coming year could bring about lots of stock market opportunities for brave investors willing to stomach risk. Mark Hartley…

Read more »

Investing Articles

ChatGPT thinks these are the 5 best FTSE stocks to consider buying for 2026!

Can the AI bot come up trumps when asked to select the best FTSE stocks to buy as we enter…

Read more »

Investing For Beginners

How much do you need in an ISA to make the average UK salary in passive income?

Jon Smith runs through how an ISA can help to yield substantial income for a patient long-term investor, and includes…

Read more »

Investing Articles

3 FTSE 250 shares to consider for income, growth, and value in 2026!

As the dawn of a new year in the stock market approaches, our writer eyes a trio of FTSE 250…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Want to be a hit in the stock market? Here are 3 things super-successful investors do

Dreaming of strong performance when investing in the stock market? Christopher Ruane shares a trio of approaches used by some…

Read more »